PD-L1
Clinical trials for PD-L1 explained in plain language.
Never miss a new study
Get alerted when new PD-L1 trials appear
Sign up with your email to follow new studies for PD-L1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation and immunotherapy join forces against tough pancreatic cancer
Disease control Recruiting nowThis early-phase study is testing whether adding low-dose radiation and an immunotherapy drug called pucotenlimab to standard chemotherapy can help control advanced pancreatic cancer. Ten adults with pancreatic cancer who haven't had prior immunotherapy will receive the combinati…
Matched conditions: PD-L1
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Could a simple scan replace biopsies for key cancer marker?
Diagnosis Recruiting nowThis study tests a new radioactive tracer called 68Ga-NK224 that lights up PD-L1, a protein on cancer cells, during a PET/CT scan. Researchers want to see if the scan can accurately measure PD-L1 levels compared to standard tissue biopsy. One hundred adults with various cancers w…
Matched conditions: PD-L1
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC